Specialist / Principal Scientist - hIPSCs-based Biomarker Discovery
Denne stilling er desværre ikke længere ledig.
Se alle ledige stillinger
Måløv
Are you an expert in the field of human induced pluripotent stem cells (hiPSCs)? Do you have a deep passion for using hiPSCs for biomarker discovery and qualification, driven by a thorough understanding of drug and disease mechanisms? Then this opportunity could be the perfect fit for you. Take the next step and apply today to become part of our committed team of international scientists. The position
As a Specialist / Principal Scientist in Translational Research, you will be discovering and qualifying new biomarkers using human iPSC-derived cells to de-risk early clinical programs. The role offers exciting scientific opportunities, a significant level of autonomy, and the chance to work closely with peers throughout the entire translational value chain. Drive experimental biomarker discovery and qualification efforts using human iPSC-derived cells Implement hIPSC-based model systems to profile Target Engagement (TE)-, Proof-of-Mechanism (PoM)- and disease modulation biomarkers Foster close-knit collaboration with computational biologists / therapy area experts and leverage the disease biology knowledge to deliver qualified biomarkers in translational project teams Mentor, train and develop junior colleagues while providing strong guidance and expertise in iPSC biology and biomarker discovery Map scientific and technology gaps in the area and lead strategic collaborations /partnerships to complement internal biomarker discovery and qualification efforts
Qualifications You hold a Ph.D. in Life Sciences with 5 - 8 years of research experience in human iPSC-based biomarker discovery within metabolic diseases or related fields, part of the expertise derived from drug discovery experience in pharma, biotech, or academia. Alternatively, you come with a Master’s in Life Sciences combined with 9 - 12 years of research experience in the field as described above. To thrive and succeed in the role, you have: Demonstrated expertise in utilizing human iPSCs for biomarker discovery & qualification within cardiometabolic space Hands-on-experience in the maintenance, manipulation, and differentiation of hiPSCs towards cell types relevant for cardio-metabolic diseases Experience in high throughput screening using nucleic acid sequencing-based technologies such as RNA-sequencing (bulk, single-cell, and spatial), DNA methylation and Olink Flair for data analysis and integration, including proficiency in R packages, AI tools, gene-set/ pathway analysis and data visualization software Ability to work with large biological datasets such as transcriptomics and proteomics as well as extract and integrate information from external databases / published literature (e.g., HPA, GTEX, Tabula Sapiens) As a person, you exhibit a strong translational mindset, exceptional networking skills, a proactive approach, and outstanding communication abilities. Being a dedicated team player is a key attribute we are seeking in potential candidates. About The Department At the Biomarker Discovery & Qualification department, we discover and qualify TE, PoM and disease modulation biomarkers. We employ human in vitro / ex vivo systems and in vivo animal models as well as apply omics technologies to generate high-quality biomarker data to guide decision-making in research and early development. Currently, the department consists of 9 scientists and is part of the Translational Research VP area. Other departments in Translational Research include Biomarker Assay Development, Omics Technologies and Translational Imaging. Translational Research is part of Global Translation, an organisational area responsible for the application of translational approaches across all the therapy areas in Novo Nordisk. Our ambitious goal is to ensure early, data-driven decision-making in clinical trials by application of target engagement, proof-of-mechanism, and disease modulation biomarkers as well as enabling precision medicine. Global Translation is part of Novo Nordisk´s Research & Early Development and is located in Måløv, Greater Copenhagen.
Working at Novo Nordisk At Novo Nordisk, we do not wait for change. We drive it. We are a dynamic company in an even more dynamic industry, and we know that what got us to where we are today is not necessarily what will make us successful in the future. We embrace the spirit of experimentation, striving for excellence, without fixating on perfection. We never shy away from opportunities to develop we seize them. From research and development to manufacturing, marketing, and sales – we’re all working to move the needle on patient care.
Contact For further information, please contact Madhan Selvaraj, Director Biomarker Discovery & Qualification at [email protected].
Deadline
25 February 2024. Applications will be reviewed on an ongoing basis, so we encourage you to apply as soon as possible. You do not need to attach a cover letter to your application, but please include a few sentences about why you are applying in your resume or CV. To ensure an efficient and fair recruitment process, please refrain from adding a photo to your CV.
We commit to an inclusive recruitment process and equality of opportunity for all our job applicants. At Novo Nordisk we recognize that it is no longer good enough to aspire to be the best company in the world. We need to aspire to be the best company for the world and we know that this is only possible with talented employees with diverse perspectives, backgrounds and cultures. We are therefore committed to creating an inclusive culture that celebrates the diversity of our employees, the patients we serve and communities we operate in. Together, we’re life changing.
As a Specialist / Principal Scientist in Translational Research, you will be discovering and qualifying new biomarkers using human iPSC-derived cells to de-risk early clinical programs. The role offers exciting scientific opportunities, a significant level of autonomy, and the chance to work closely with peers throughout the entire translational value chain.
Qualifications You hold a Ph.D. in Life Sciences with 5 - 8 years of research experience in human iPSC-based biomarker discovery within metabolic diseases or related fields, part of the expertise derived from drug discovery experience in pharma, biotech, or academia. Alternatively, you come with a Master’s in Life Sciences combined with 9 - 12 years of research experience in the field as described above. To thrive and succeed in the role, you have:
Working at Novo Nordisk At Novo Nordisk, we do not wait for change. We drive it. We are a dynamic company in an even more dynamic industry, and we know that what got us to where we are today is not necessarily what will make us successful in the future. We embrace the spirit of experimentation, striving for excellence, without fixating on perfection. We never shy away from opportunities to develop we seize them. From research and development to manufacturing, marketing, and sales – we’re all working to move the needle on patient care.
Contact For further information, please contact Madhan Selvaraj, Director Biomarker Discovery & Qualification at [email protected].
Deadline
25 February 2024. Applications will be reviewed on an ongoing basis, so we encourage you to apply as soon as possible. You do not need to attach a cover letter to your application, but please include a few sentences about why you are applying in your resume or CV. To ensure an efficient and fair recruitment process, please refrain from adding a photo to your CV.
We commit to an inclusive recruitment process and equality of opportunity for all our job applicants. At Novo Nordisk we recognize that it is no longer good enough to aspire to be the best company in the world. We need to aspire to be the best company for the world and we know that this is only possible with talented employees with diverse perspectives, backgrounds and cultures. We are therefore committed to creating an inclusive culture that celebrates the diversity of our employees, the patients we serve and communities we operate in. Together, we’re life changing.
Information og data
Denne ledige stilling har jobtypen "Forretningsudvikler", og befinder sig i kategorien "Kommunikation, marketing, salg".
Arbejdsstedet er beliggende i Måløv.
Jobbet er oprettet på vores service den 6.11.2023, men kan have været deaktiveret og genaktiveret igen.
Dagligt opdateret: Dette job opdateres dagligt ud fra jobudbyderens hjemmeside via vores søgemaskineteknologi og er aktivt lige nu.
- Forretningsudvikler
- Måløv
Lignende jobs
-
Strategic Trial Planning Manager - Clinical Develo...
Are you ready to drive the successful strategic planning and management of early phase clinical trials, i.e. ClinPharm/Phase 1 studies? Does oversight and cross functional collaboration motivate yo..Få mere info- Forretningsudvikler
- Søborg
-
Senior Scientist in Late-stage Downstream Developm...
Are you ready to shape the future of API process characterization in late-stage downstream development? Do you have the expertise to drive innovative solutions and ensure seamless tech transfer in .Få mere info- Forretningsudvikler
- Bagsværd
-
Global Trial Manager
Are you passionate about clinical development? Is ensuring that clinical trials produce high-quality data and scientific documentation your top priority? If so, we want you to join our team in Card..Få mere info- Forretningsudvikler
- Søborg
-
Udviklingskonsulent til det sociale børne- og unge...
Få mere info- Forretningsudvikler
- Taastrup
Statistik over udbudte jobs som forretningsudviklere i Måløv
Herunder ser du udviklingen i udbudte forretningsudvikler i Måløv over tid. Bemærk at jobs der ikke har en bestemt geografi ikke er medtaget i tabellen. I den første kolonne ser du datoen. I den næste kolonne ser du det samlede antal forretningsudviklere.
Se flere statistikker her:
Statistik over udbudte forretningsudviklere i Måløv over tid
| Dato | Alle jobs som forretningsudviklere |
|---|---|
| 22. november 2024 | 3 |
| 21. november 2024 | 3 |
| 20. november 2024 | 4 |
| 19. november 2024 | 3 |
| 18. november 2024 | 3 |
| 17. november 2024 | 5 |
| 16. november 2024 | 5 |
| 15. november 2024 | 5 |
| 14. november 2024 | 5 |
| 13. november 2024 | 5 |
| 12. november 2024 | 5 |
| 11. november 2024 | 4 |
| 10. november 2024 | 4 |
| 9. november 2024 | 4 |
| 8. november 2024 | 3 |
| 7. november 2024 | 2 |
| 6. november 2024 | 1 |
| 5. november 2024 | 1 |
| 4. november 2024 | 1 |
| 3. november 2024 | 3 |
| 2. november 2024 | 3 |
| 1. november 2024 | 3 |
| 31. oktober 2024 | 4 |
| 30. oktober 2024 | 4 |
| 29. oktober 2024 | 4 |
| 28. oktober 2024 | 4 |
| 27. oktober 2024 | 6 |
| 26. oktober 2024 | 6 |
| 25. oktober 2024 | 7 |
| 24. oktober 2024 | 7 |
| 23. oktober 2024 | 7 |